Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, and it remains incurable. Currently there is no definitive biomarker for detecting PD, measuring its severity, or monitoring of treatments. Recently, oculomotor fixation abnormalities have emerged as a sensitive biomarker to discriminate Parkinsonian patterns from a control population, even at early stages.
View Article and Find Full Text PDF